Drug Profile
GW 274150
Alternative Names: 274150; GSK 274150Latest Information Update: 02 Aug 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Antiallergics; Antiasthmatics; Small molecules; Sulfides
- Mechanism of Action Nitric oxide synthase type II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic rhinitis; Asthma; Chronic obstructive pulmonary disease; Migraine; Rheumatoid arthritis